Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The apical conjugate efflux pump ABCC2 (MRP2).

Anne T Nies1, Dietrich Keppler

  • 1Division of Tumor Biochemistry, German Cancer Research Center, Heidelberg, Germany. a.nies@dkfz.de

Pflugers Archiv : European Journal of Physiology
|July 19, 2006
PubMed
Summary

The ABCC2 transporter protein is crucial for excreting organic anions and detoxifying substances in cells like hepatocytes. Its deficiency, seen in Dubin-Johnson syndrome, leads to elevated bilirubin glucuronosides due to compensatory efflux mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids-Application to recent real-world cases.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Feed-Forward Deep Neural Networks Predict Substrate-Specific Effects of Transporter Variants to Explain Drug Response Variability.

Clinical and translational science·2026
Same author

Identification of Brimonidine as a Novel Substrate of Organic Cation Transporters OCT2 and MATE1 Expressed in Human Eye.

Investigative ophthalmology & visual science·2026
Same author

Humanized Fruit Flies as a Novel Pre-Clinical Test Model for Membrane Drug Transporters.

Frontiers in bioscience (Landmark edition)·2025
Same author

In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variants.

British journal of pharmacology·2024
Same author

Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation.

Pharmacological research·2023

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • ABCC2 is an apical membrane transporter protein in polarized cells.
  • It plays a key role in the excretion and detoxification of organic anions.
  • ABCC2 is involved in transporting conjugates like bilirubin glucuronosides.

Purpose of the Study:

  • To provide an overview of ABCC2's molecular characteristics and tissue expression.
  • To discuss the regulation of ABCC2 at transcriptional and posttranscriptional levels.
  • To review functional analysis methods and substrate specificity of ABCC2.

Main Methods:

  • Literature review on ABCC2 molecular characteristics, expression, and regulation.
  • Analysis of functional studies and substrate specificity data.

Related Experiment Videos

  • Compilation and assessment of human ABCC2 gene sequence variants and their consequences.

    • Main Results:

    • ABCC2's localization to apical membranes facilitates the efflux of xenobiotics and endogenous compounds.
    • Deficiency in ABCC2, as in Dubin-Johnson syndrome, results in elevated bilirubin glucuronosides.
    • Alternative transporter ABCC3 compensates for ABCC2 deficiency via basolateral efflux.
    • A comprehensive list of ABCC2 variants and their functional impacts is presented.

    Conclusions:

    • ABCC2 is vital for cellular detoxification and excretion, particularly in the liver and kidney.
    • Understanding ABCC2 variants is crucial for diagnosing and managing conditions like Dubin-Johnson syndrome.
    • Further research into ABCC2 regulation and function can inform therapeutic strategies.